What treats thrombocytosis?

Our catalog lists 2 products that may treat thrombocytosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is anagrelide hydrochloride.

What is the best-rated treatment for thrombocytosis?

By our independent recall-safety rating — not an efficacy measure — anagrelide hydrochloride ranks highest among the products we list for thrombocytosis. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat thrombocytosis?

Treatments for thrombocytosis span FDA drug classes including platelet-reducing agent. Compare every option side by side, ranked by independent rating, above.

Best treatments for thrombocytosis

2 products may treat thrombocytosis, spanning FDA drug classes such as platelet-reducing agent. The current highest-rated option is anagrelide hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for thrombocytosis, all are available as lower-cost generics, spanning classes such as platelet-reducing agent. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for thrombocytosis — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Treatments we list for thrombocytosis
#	Drug	Rating	Type	Form	Class	Generic?	Pharmacy pays
1	Anagrelide Hydrochloride	70/100	Prescription	Capsule	Platelet-reducing Agent	Generic	$33	View →
2	Agrylin	Not yet rated	Prescription	Capsule	Platelet-reducing Agent	Generic	$33	View →

Narrow by drug class

Best platelet-reducing agent for thrombocytosis (2)

Explore the class hubs: platelet-reducing agent

Full ranking · 2 treatments

anagrelide hydrochloride

PrescriptionFDA-sourced

70/100

Anagrelide Hydrochloride is a platelet-reducing agent used to treat Polycythemia Vera, Thrombocytosis.

(2 data points)

platelet-reducing agentpolycythemia verathrombocytosis

Pharmacy pays

From ~$21.79/30· 2 forms

View details →

agrylin

PrescriptionFDA-sourced

New

Agrylin (Anagrelide Hydrochloride) is a platelet-reducing agent used to treat Polycythemia Vera, Thrombocytosis.

platelet-reducing agentpolycythemia verathrombocytosis

Pharmacy pays

From ~$21.79/30· 2 forms

View details →

Frequently asked

What treats thrombocytosis?: Our catalog lists 2 products that may treat thrombocytosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is anagrelide hydrochloride.
What is the best-rated treatment for thrombocytosis?: By our independent recall-safety rating — not an efficacy measure — anagrelide hydrochloride ranks highest among the products we list for thrombocytosis. Always consult a professional.
How are these treatments ranked?: By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat thrombocytosis?: Treatments for thrombocytosis span FDA drug classes including platelet-reducing agent. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.